Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
Saved in:
Main Authors: | Jing Sun (Author), Juanjuan Chen (Author), Qinfang Xie (Author), Mengjiao Sun (Author), Wenjing Zhang (Author), Hongxia Wang (Author), Ning Liu (Author), Qi Wang (Author), Manxia Wang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2023) -
The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review
by: Giuseppe Schirò, et al.
Published: (2023) -
Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota
by: Senhui Weng, et al.
Published: (2023) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016) -
Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018)